In Vitro In Vivo
In Vitro In Vivo - Related Videos
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
0 Views •
Cited by 28 •
2017
Here, optimized methods to generate in vivo and in vitro models of hepatic steatosis and to analyze the steatotic phenotypes and related physiological parameters are described.
05:14
Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
0 Views •
2025
Given the limited xenograft models available to study interactions between human CART and myeloid cells, we established in vitro and in vivo models to understand the impacts of human macrophages on CART cells. Findings can potentially be generalized to evaluate macrophage roles in the tumor microenvironment and test macrophage-targeted immunotherapies.
08:25
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
0 Views •
Cited by 21 •
2020
This procedure was established to be used for developing advanced 3D hepatic cultures in vitro, which can provide a more physiologically relevant assessment of the genotoxic hazards associated with nanomaterial exposures over both an acute or long-term, repeated dose regimes.
09:05
In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
0 Views •
Cited by 7 •
2016
A primary culture of bovine corneal endothelial cells was used to investigate the mechanism of corneal endothelial-mesenchymal transition. Furthermore, a rat corneal endothelium cryoinjury model was used to demonstrate corneal endothelial-mesenchymal transition in vivo.
11:44
Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo
0 Views •
Cited by 1 •
2014
The aim of the protocol is to use optimal methods for stimulating the cytoplasmic DNA sensing pathways in cells and in vivo. This is achieved by improving the generation of long, double-stranded DNA during blunt-end ligation. Cells or mice are then transfected using a lipid transfection reagent.
FAQs
Their greatest value comes from combining controlled observation with biological realism. In vitro experiments can examine drug activity or toxicity under defined conditions, while in vivo studies show how circulation, metabolism, immune activity, and tissue interactions influence those responses. Comparing the two helps researchers identify which laboratory findings remain relevant in a living organism and which require further investigation.
The surrounding biological conditions can change the observed response. A controlled laboratory system may not reproduce the circulation, metabolism, immune activity, or tissue interactions present in a living organism. Consequently, a result observed in vitro may change during in vivo evaluation, affecting apparent drug activity, toxicity, pharmacokinetics, or therapeutic effectiveness.
The comparison shows both the usefulness and the limitations of simplified laboratory models. In vitro systems can isolate biological processes and support defined measurements, but they may not capture the coordinated influences present in a living organism. In vivo results provide additional context for judging whether an experimental finding is sufficiently relevant to support medical development.
Researchers can begin by examining a biological response under controlled in vitro conditions, then assess related effects in vivo to determine how the response changes within a living organism. This progression connects early laboratory observations with evidence from a more complex biological setting. Comparing outcomes at each stage supports decisions about whether findings warrant continued evaluation.
Together, these approaches can support evaluation of drug activity, toxicity, pharmacokinetics, and therapeutic effectiveness. In vitro testing helps characterize responses in cells, tissues, or biological molecules under defined conditions, while in vivo assessment indicates how those responses are shaped by the organism. The combined evidence gives researchers a broader basis for judging medical interventions.
It helps researchers avoid relying solely on results from a simplified laboratory environment or solely on observations from a living organism. By comparing both types of evidence, investigators can examine whether activity and toxicity findings translate across experimental settings. This supports evidence-based medical decisions and contributes to the development of treatments that are more clinically relevant and safer.